Association between serum ferritin levels and mild cognitive impairment risk in middle-aged and older adults: evidence from the health and retirement study
- 1Department of Neurology, Meizhou People’s Hospital
Abstract
Background: Ferritin serves as the main iron-storage form in the human body. Iron ions are critical for numerous brain-related physiological processes. This study aimed to explore the association between serum ferritin levels and the risk of mild cognitive impairment (MCI) in middle-aged and older adults.
Methods: Participants aged 50 years and above with available cognitive function assessments were selected from the Health and Retirement Study (HRS) database. Baseline data for this retrospective cohort study were collected in 2016, and MCI occurrence was recorded through 2022. Cognitive function was assessed using tests of episodic memory and executive function. The primary MCI outcome was based on an operational cognitive-score definition rather than a clinical MCI diagnosis: the cognitive function score was at least one standard deviation (SD) below the age-specific normative value. Cox regression models were employed to explore the association between serum ferritin [tertiles: <76 μg/L, 76-151 μg/L (reference group), ≥151 μg/L] and MCI risk, as well as impairments in episodic memory and executive function.
Results: A total of 6,572 participants were enrolled in the analytical cohort. Of these, 1,435 (21.84%) participants developed MCI, while 5,137 (78.16%) were free of MCI events. Individuals with serum ferritin ≥151 μg/L were related to a higher risk of MCI [HR = 1.15 (95%CI: 1.01–1.31)] compared to those with serum ferritin 76-151 μg/L, but no association was found in those with serum ferritin <76 μg/L [HR = 1.04 (95%CI: 0.91–1.19)]. Serum ferritin levels showed a significant U-shaped non-linear association with MCI risk ( P non-linear = 0.03). Moreover, individuals with serum ferritin ≥151 μg/L were associated with a higher risk of episodic memory impairment [HR = 1.15 (95%CI: 1.01–1.30)] versus those with serum ferritin 76–151 μg/L. No significant associations were found between serum ferritin and executive dysfunction [HR = 0.99 (95%CI: 0.90–1.10)].
Conclusion: High serum ferritin levels were associated with an increased risk of MCI among middle-aged and older adults, especially episodic memory impairment.
Related
- Plasma p-tau181 moderates the association between ten-year atherosclerotic cardiovascular disease risk and mild cognitive impairment – HABS-HD
- Association of conventional and non-conventional lipid profile with cognitive impairment among type 2 diabetic patients
- Association between long-term air quality index exposure and multidimensional study-defined cognitive impairment in middle-aged and older adults
- FDG PET evidence suggests the left insula may be a hub for cognitive reserve in mild cognitive impairment
- Association between PCSK9 and post-stroke cognitive impairment: a retrospective cohort study and predictive models establishment based on machine learning.
BibTeX
@article{qiu2026association,
title = {{Association between serum ferritin levels and mild cognitive impairment risk in middle-aged and older adults: evidence from the health and retirement study}},
author = {Wei Qiu and Jiashan Tu and Hong Wang},
journal = {Frontiers in Neurology},
year = {2026},
month = nov,
doi = {10.3389/fneur.2026.1932489},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1932489/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Association between serum ferritin levels and mild cognitive impairment risk in middle-aged and older adults: evidence from the health and retirement study
AU - Wei Qiu
AU - Jiashan Tu
AU - Hong Wang
PY - 2026
DA - 2026/11/02
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1932489
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1932489/full
AB - Background: Ferritin serves as the main iron-storage form in the human body. Iron ions are critical for numerous brain-related physiological processes. This study aimed to explore the association between serum ferritin levels and the risk of mild cognitive impairment (MCI) in middle-aged and older adults. Methods: Participants aged 50 years and above with available cognitive function assessments were selected from the Health and Retirement Study (HRS) database. Baseline data for this retrospective cohort study were collected in 2016, and MCI occurrence was recorded through 2022. Cognitive function was assessed using tests of episodic memory and executive function. The primary MCI outcome was based on an operational cognitive-score definition rather than a clinical MCI diagnosis: the cognitive function score was at least one standard deviation (SD) below the age-specific normative value. Cox regression models were employed to explore the association between serum ferritin [tertiles: <76 μg/L, 76-151 μg/L (reference group), ≥151 μg/L] and MCI risk, as well as impairments in episodic memory and executive function. Results: A total of 6,572 participants were enrolled in the analytical cohort. Of these, 1,435 (21.84%) participants developed MCI, while 5,137 (78.16%) were free of MCI events. Individuals with serum ferritin ≥151 μg/L were related to a higher risk of MCI [HR = 1.15 (95%CI: 1.01–1.31)] compared to those with serum ferritin 76-151 μg/L, but no association was found in those with serum ferritin <76 μg/L [HR = 1.04 (95%CI: 0.91–1.19)]. Serum ferritin levels showed a significant U-shaped non-linear association with MCI risk ( P non-linear = 0.03). Moreover, individuals with serum ferritin ≥151 μg/L were associated with a higher risk of episodic memory impairment [HR = 1.15 (95%CI: 1.01–1.30)] versus those with serum ferritin 76–151 μg/L. No significant associations were found between serum ferritin and executive dysfunction [HR = 0.99 (95%CI: 0.90–1.10)]. Conclusion: High serum ferritin levels were associated with an increased risk of MCI among middle-aged and older adults, especially episodic memory impairment.
SN - 1664-2295
ER -